US Patent Issued to NeuroPn Therapeutics on Sept. 15 for "Piperidine urea derivatives for cancer therapy" (Monegasque, Monacan, American, Null Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,164, issued on Sept. 15, was assigned to NeuroPn Therapeutics Inc. (Peachtree Corners, Ga.).

"Piperidine urea derivatives for cancer therapy" was invented by Ish Khanna (Alpharetta, Ga.), Sivaram Pillarisetti (Peachtree Corners, Ga.), Hans Marcus Malkmus (Monaco, Monaco) and Kathrin Christin Kortschak (Providenciales, Turks and Caicos Islands).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are novel piperidine urea derived compounds and their pharmaceutical compositions for the treatment of cancer as a monotherapy or a combination therapy with chemotherapeutic agents and/or checkpoint inhibitors."

The patent was filed on Sept. 29, ...